A randomized placebo‐controlled trial assessing sphenopalatine ganglion block in endoscopic sinus surgery

2021 ◽  
Author(s):  
Martin Morisse ◽  
Bénédicte Rysman ◽  
Claire Szymanski ◽  
Rémi Fackeure ◽  
François Mouawad ◽  
...  
Keyword(s):  
Endoscopic Sinus Surgery ◽  
Controlled Trial ◽  
Sinus Surgery ◽  
Sphenopalatine Ganglion ◽  
Ganglion Block ◽  
Sphenopalatine Ganglion Block

scholarly journals Effect of Sphenopalatine Ganglion Block With Bupivacaine on Postoperative Pain in Patients Undergoing Endoscopic Sinus Surgery

2019 ◽  
Vol 10 ◽  
pp. 215265671882128 ◽  
Author(s):  
Ahmad Rezaeian ◽  
Seyed Mostafa Hashemi ◽  
Zeinab Sadat Dokhanchi
Keyword(s):  
Postoperative Pain ◽  
Endoscopic Sinus Surgery ◽  
Intervention Group ◽  
Sinus Surgery ◽  
Control Group ◽  
Sphenopalatine Ganglion ◽  
Ganglion Block ◽  
Rescue Analgesia ◽  
Sphenopalatine Ganglion Block ◽  
And Control

Background Postoperative pain is one of the most complications in endoscopic sinus surgery. We aimed to evaluate the effect of the sphenopalatine ganglion block (SPGB) with bupivacaine on postoperative pain in patients undergoing endoscopic sinus surgery. Methods and Materials: In this clinical trial, 40 patients who indicated functional endoscopic sinus surgery were selected and then divided into 2 parallel groups as intervention and control. The intervention group was received 1.5 mL of bupivacaine 0.5% (injected to sphenopalatine ganglion) and while control was injected 1.5 mL of normal saline at the same injection site. Also, the visual analogue scale (VAS) was recorded immediately after anesthesia, along with 6, 12, 24, 48 h, 7 days, and 21 days after the operation for all patients. Results Immediately after anesthesia, as well as 6, 12, and 24 h after the operation, VAS in the intervention group was significantly lower than in the control group ( P < .05, for all). However, there were no significant differences between the 2 groups regarding VAS 48 h as well as 7 and 21 days after surgery ( P > .05, for both). Also, the rescue analgesia in the intervention group was significantly lower than in the control group ( P = .01). Conclusion SPGB with bupivacaine 0.5% (1.5 mL) was a simple, effective, safe, and noninvasive method for the management of postoperative pain in the patients undergoing endoscopic sinus surgery.

Does Sphenopalatine Ganglion Block Improve Pain Control and Intraoperative Hemodynamics in Children Undergoing Palatoplasty? A Randomized Controlled Trial

2018 ◽  
Vol 76 (9) ◽  
pp. 1873-1881 ◽  
Author(s):  
Anantanarayanan Parameswaran ◽  
Muruganand V. Ganeshmurthy ◽  
Yashoda Ashok ◽  
Manikandhan Ramanathan ◽  
Anthony F. Markus ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Pain Control ◽  
Controlled Trial ◽  
Sphenopalatine Ganglion ◽  
Ganglion Block ◽  
Randomized Controlled ◽  
Sphenopalatine Ganglion Block

The Role of Endoscopic Sphenopalatine Ganglion Block on Nausea and Vomiting After Sinus Surgery

2018 ◽  
Vol 32 (5) ◽  
pp. 369-373 ◽  
Author(s):  
Ahmad K. Abubaker ◽  
Mohannad A. Al-Qudah
Keyword(s):  
General Anesthesia ◽  
Endoscopic Sinus Surgery ◽  
Oral Feeding ◽  
Nausea And Vomiting ◽  
Sinus Surgery ◽  
Controlled Study ◽  
Sphenopalatine Ganglion ◽  
Ganglion Block ◽  
Early Recovery ◽  
Double Blind

Background Postoperative nausea and vomiting (PONV) are among the most common unpleasant and distressing adverse events following surgery under general anesthesia. Functional endoscopic sinus surgery (FESS) is a common otolaryngology procedure. Prevention of PONV and early recovery are cost-effective. Objective The aim of this study was to evaluate the prophylactic effect of bilateral endoscopic injection of lidocaine with epinephrine in the sphenopalatine ganglion (SPG) on PONV in patients undergoing FESS. Methods One hundred patients with chronic rhinosinusitis undergoing general anesthesia for FESS were enrolled in this double-blind, placebo-controlled study. Patients were randomized to receive injection of 2 mL of 2% lidocaine with epinephrine or 2 mL of saline at the end of surgery. Postoperatively, patients were observed for 24 h. PONV was evaluated immediately, 6 h, and 24 h after surgery. Results The 2 groups were comparable in characteristic and intraoperative features. In general, the incidence of PONV after FESS was 36%. The average time that patients can tolerate oral feeding was 3.4 h after surgery. Endoscopic SPG injection with lidocaine significantly reduced the incidence of vomiting and PONV. In addition, SPG injection with lidocaine reduced the incidence of severe vomiting and decreased the number of vomiting episodes. No complications were encountered in either group. Conclusion SPG injection with lidocaine at the end of surgery is a safe, noninvasive, and an effective technique in reducing early PONV in endoscopic sinus surgery patients.

Sign in / Sign up

Export Citation Format

Share Document